Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05345483 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT)

Study acronym: RECHRUT
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 5, 2024 (before its estimated September 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 12 to 17
    • Eligibility criteria expanded, about 66 words
    v4
  2. Study sites: 1 to 12v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Sep 2025 to Sep 2026
    • Start date changed from estimate of Sep 2022 to Jan 25, 2023
    • Study completion date: Jan 2026 to Jan 2027
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Goal of the study is to evaluate the efficacy and safety of acute permanent stenting of symptomatic intracranial stenosis following unsuccessful recanalization by thrombectomy in acute ischemic stroke with large vessel occlusion using the self-expandable CREDO® heal Stent.
Trial Details
NCT Number NCT05345483
Lead Sponsor Acandis GmbH
Conditions
(from sponsor)		 Rescue Stenting
Enrollment 153 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov